In the midst of a pandemic, Luce’s journey routine mammogram took a quick turn, emphasizing the importance of routine screenings. Her story is a testament to the life-saving impact of early detection.

At 51 years old, Luce began her journey when her second annual mammogram beckoned. Initially, she contemplated delaying her routine screening due to the challenges posed by the pandemic. However, with her sister’s encouragement, she carried on with her appointment, a decision she will always be grateful for.

After the mammogram, the doctors’ call back for additional tests led to a swift diagnosis of stage 0 breast cancer. But the story didn’t end there. Within four weeks, the tiny 0.5mm tumor rapidly evolved into stage 2 breast cancer. This astonishing transformation underscored the value of early detection and the essential role that routine mammograms play in diagnosing breast cancer in its early, more treatable stages.

Luce’s experience also shines a light on the critical role research has played in improving breast cancer outcomes. It’s research that has led to the discovery of over 50 types of breast cancer and the on-going development of more effective treatments for each and every type.

Throughout her journey, the pandemic imposed isolation, making it challenging to maintain a support system. Yet, Luce’s determination and her discipline pushed her forward. Her passion for half marathons kept her moving and spending time outdoors. As treatment proceeded, her body underwent significant changes, but her spirit remained unbreakable.

Fortunately, Luce’s immediate and timely treatment turned her dire situation into a story of recovery. Today, Luce is living proof of the progress made through research and early detection. She’s running again, setting her sights on competitions, and is happily back in the classroom teaching grade three.